GlassScriptPhysician profile
Lisa J Dillard
NPI 1831153212
$3,798.13
in general payments reported to CMS, 2019-2025
31 companies · $966 in 2025
The $966 reported for 2025 was more than what 84% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $458 · 2020: $192 · 2021: $37.96 · 2022: $273 · 2023: $894 · 2024: $976 · 2025: $966.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,791 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,791.05 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $848.05 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Lilly USA, LLC | $503.79 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $388.33 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $220.04 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $215.14 | 2020-2025 | Jardiance |
| Abbvie INC. | $203.11 | 2019-2025 | Vraylar |
| Novartis Pharmaceuticals Corporation | $186.20 | 2022-2025 | |
| Exact Sciences Corporation | $121.64 | 2023-2025 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $108.04 | 2023-2025 | Arexvy, Shingrix |
| Viiv Healthcare Company | $107.54 | 2024-2025 | Apretude |
| Abbott Laboratories | $92.18 | 2021-2025 | Freestyle Libre 3 |
| Bayer Healthcare Pharmaceuticals INC. | $85.37 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $74.81 | 2019-2024 | Gardasil 9, Capvaxive, Gardasil |
| Gilead Sciences, INC. | $64.69 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $55.73 | 2019 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $49.87 | 2025 | Veozah |
| Amgen INC. | $47.33 | 2019-2024 | Otezla, Repatha |
| Esperion Therapeutics, INC. | $46.15 | 2024-2025 | Nexletol |
| Teva Pharmaceuticals USA, INC. | $43.00 | 2019 | |
| Amarin Pharma, INC. | $38.88 | 2020-2021 | |
| Dexcom, INC. | $38.46 | 2023-2024 | Dexcom G6 Transmitter |
| Otsuka America Pharmaceutical, INC. | $38.00 | 2024-2025 | Jynarque, Rexulti |
| Azurity Pharmaceuticals, INC. | $32.61 | 2023 | Horizant, Edarbyclor |
| Dynavax Technologies Corporation | $31.20 | 2024 | Heplisav-B |
| Medtronic, INC. | $30.54 | 2023-2025 | Venaseal |
| Allergan, INC. | $28.64 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $25.81 | 2020 | |
| Vanda Pharmaceuticals INC. | $21.30 | 2022 | |
| Idorsia Pharmaceuticals US INC | $20.18 | 2023 | Quviviq |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.05 | 2024 | Xifaxan, Trulance |
| Takeda Pharmaceuticals U.S.A., INC. | $15.45 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Dillard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.